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Abstract
Virus infection of mammalian cells induces the production of high levels of type I interferons (IFNa and b), cytokines that
orchestrate antiviral innate and adaptive immunity. Previous studies have shown that only a fraction of the infected cells
produce IFN. However, the mechanisms responsible for this stochastic expression are poorly understood. Here we report an
in depth analysis of IFN-expressing and non-expressing mouse cells infected with Sendai virus. Mouse embryonic fibroblasts
in which an internal ribosome entry site/yellow fluorescent protein gene was inserted downstream from the endogenous
IFNb gene were used to distinguish between the two cell types, and they were isolated from each other using fluorescence-
activated cell sorting methods. Analysis of the separated cells revealed that stochastic IFNb expression is a consequence of
cell-to-cell variability in the levels and/or activities of limiting components at every level of the virus induction process,
ranging from viral replication and expression, to the sensing of viral RNA by host factors, to activation of the signaling
pathway, to the levels of activated transcription factors. We propose that this highly complex stochastic IFNb gene
expression evolved to optimize both the level and distribution of type I IFNs in response to virus infection.
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Introduction
Eukaryotic cells respond to extracellular signals and environ-
mental stresses by coordinately activating specific sets of genes.
Signals from the cell surface or cytoplasm trigger signaling
pathways that culminate in the binding of distinct combinations
of coordinately activated transcription factors to promoter and
enhancer elements that regulate gene expression. A well-
characterized example of this is the activation of type I interferon
(IFN) gene expression in response to virus infection or double-
stranded RNA (dsRNA) treatment [1,2]. After infection, viral
RNA is detected in the cytoplasm by one of two RNA helicases,
retinoic acid-inducible gene I (RIG-I) or melanoma differentia-
tion-associated gene 5 (MDA5), which respond to different types of
viruses [3]. RIG-I recognizes short dsRNA or panhandle RNA
bearing a 59 triphosphate group [3], and its activity is positively
regulated by the ubiquitin E3 ligase tripartite motif 25 (Trim25)
[4]. When RIG-I or MDA5 bind to RNA, they form heterodimers,
undergo a conformational change, and expose a critical N-
terminal caspase-recruiting domain (CARD) [5,6]. This domain
interacts with the CARD domain of the downstream adaptor
protein mitochondrial antiviral signaling (MAVS) (also known as
IPS-1/Cardif/VISA) on the mitochondrial membrane [7]. The
association of RIG-I with MAVS initiates the recruitment of
adaptor proteins and leads to the activation of the transcription
factors IFN regulatory factors 3 and 7 (IRF3 and IRF7) and NF-
kB by the TANK-binding kinase 1 (TBK1) [8–10] and IKKa and
IKKb, respectively [7,11]. Activated IRF3/IRF7 and NF-kB
translocate into the nucleus and, along with the transcription
factors ATF2/cJun, bind the IFN-b gene enhancer and recruit
additional transcription components to form an enhanceosome
[12]. This complex signaling and promoter recognition mecha-
nism functions to coordinately activate a specific set of transcrip-
tion factors that recognize the unique enhancer sequence of the
IFNb gene and thus specifically activate IFN gene expression.
Early in situ hybridization (ISH) studies revealed that induction
of IFNb expression by virus infection or dsRNA treatment in both
human and mouse cells is stochastic [13,14]. That is, only a
fraction of the infected cells express IFNb. This ‘‘noisy’’ expression
is not due to genetic variation within the cell population, as
multiple subclones of individual cells display the same low
percentage of cells expressing IFNb [14]. In addition, different
mouse and human cell lines display different percentages of
expressed cells, and the levels of IFNb gene expression can be
increased in low expressing cell lines by fusing them with high
expressing lines, or by treating low expressing lines with IFNb
[13,14]. These studies suggest that stochastic expression of the
IFNb gene is a consequence of cell-to-cell differences in limiting
cellular components required for IFN induction, and that one or
more of the limiting factors are inducible by IFNb [13].
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cytokine genes, including IL-2 [15], IL-4 [16,17], IL-10 [18], IL-5,
and IL-13 [19]. In many of these cases, expression is both
stochastic and monoallelic. Recent studies of IFNb gene
expression revealed that stochastic expression in human cells is
initially monoallelic, and becomes biallelic later in the induction
[20,21]. In one study the stochastic expression of the IFNb gene
was proposed to be a consequence of intrinsic noise due to
stochastic enhanceosome assembly [21]. Subsequently, an analysis
of human HeLa cells identified a specific set of Alu-repetitive DNA
sequences bearing NF-kB binding sites that associate with the
IFNb gene through interchromosomal interactions, and in so
doing are thought to increase the local concentration of NF-kB.
Initially, only one of the two chromosomes associates with the
specialized NF-kB binding sequence, resulting in early monoallelic
expression. Secretion of IFN leads to an increased expression of
limiting factors (most likely IRF7, which is inducible by IFN),
obviating the need for interchromosomal interactions, and leading
to the activation of the second IFNb allele [20]. More recently,
heterogeneity in the infecting viruses, rather than cell cycle
differences, has been proposed to be the primary source of IFN
stochastic expression [22]. Many functions have been proposed for
biological noise, ranging from cell fate decisions during develop-
ment to survival in fluctuating environments [23]. In the case of
the IFN genes, neither the mechanisms nor functions of biological
noise are well understood.
Here we report a detailed analysis of stochastic IFNb gene
expression in mouse cells. We make use of an IFN-IRES-YFP
reporter mouse [24] to perform a detailed analysis of differences
between virus-infected cells that either express or do not express
IFNb. Our results reveal a complex picture of stochastic
expression of the IFNb gene, in which the levels of components
required for virtually every step in the virus induction pathway are
limiting. This includes components required for viral replication
and expression, for sensing the presence of viral RNA by the host,
and for the virus induction signaling pathway, and the transcrip-
tion factors required of IFNb gene expression. Remarkably, in
spite of this complexity the percentage of expressing cells remains
constant through recloning and cell division, indicating that the
stochasm of clonal cells is genetically programmed.
Results
Stochastic Expression of Mouse and Human IFNb Genes
Sendai virus (SeV) infection of either mouse or human cells
leads to the expression of IFNb mRNA in only a fraction of the
infected cells (Figures 1A, 1B, and S1A), and the percentage of
expressing cells differs between different cell lines. The time course
of mouse IFNb expression determined by ISH (Figure 1B) is
consistent with that from the quantitative PCR (qPCR) analysis
(Figure S1B and S1C). Remarkably, the percentage of cells
expressing IFN did not exceed 20%, even at the latest time point
(Figure 1B). The absence of IFNb signal in the majority of cells is
not an artifact of hybridization, as b-actin mRNA was detected in
all cells (Figure S1D). IFNb mRNA is specifically detected with an
antisense IFNb RNA probe, while no signal is detected with a
sense RNA probe (Figure S1E). In addition, similar percentages of
IFNb-expressing cells were detected by immunofluorescent
staining using an IFNb antibody (Figure S1F), strongly supporting
the reproducibility and specificity of the IFNb ISH.
As mentioned above, enhanceosome assembly and limiting
amounts of NF-kB have been proposed to be the primary limiting
steps in stochastic expression of the human IFNb gene [20,21]. To
determine whether this stochastic expression is unique to the IFNb
gene because of the complexity of the IFNb enhanceosome, or is
more general, we examined the expression of the IFNa genes,
which are coinduced with IFNb, but have simple enhancer/
promoters, and do not require NF-kB [25,26]. Using either a
mouse IFNa4 or human IFNa8 probe, we found that IFNa genes
are also stochastically expressed in both mouse and human cells,
respectively (Figures 1C and S1G). Although NF-kB has been
shown to be a limiting factor in the activation of the human IFNb
gene [20], it is not required for IFNb expression in mouse cells
[27]. Thus, in spite of this difference both the mouse and human
IFNb genes are stochastically expressed. We also examined other
virus-inducible genes, and found that they too are stochastically
expressed (see below). Each of these virus-inducible genes requires
different levels and combinations of transcription factors, yet they
are all stochastic. In all of these cases (mouse and human IFNb
and IFNa and the other virus-inducible genes), the common
requirement is the RIG-I virus-inducible signaling pathway. We
therefore carried out experiments to determine whether limiting
components in this pathway contribute to the observed stochastic
expression.
Separation and Characterization of IFN-Expressing and
Non-Expressing Cells
To investigate the mechanism of stochastic IFNb gene
expression, we made use of an IFNb reporter-knock-in mouse,
in which YFP expression allows tracking of IFNb expression at a
single-cell level [24]. Using IFNb/YFP homozygous mouse
embryonic fibroblasts (MEFs) and fluorescence-activated cell
sorting (FACS), we obtained pure populations of IFNb-producing
and IFNb-negative cells upon SeV infection. As expected, IFNb
mRNA is high in the YFP-positive cells, and very low in the YFP-
negative cells (Figure S2A). As expected, the IFNa2 and IFNa4
genes are also highly expressed in the YFP-positive cells, and not in
the YFP-negative cells (Figure S2A). These observations indicate
that replication of the infecting virus and/or components in the
RIG-I pathway are the limiting steps in the uninduced cells, rather
than intrinsic differences in the IFNb and a promoters.
Author Summary
Eukaryotic cells can respond to extracellular signals by
triggering the activation of specific genes. Viral infection of
mammalian cells, for example, induces a high level of
expression of type I interferons (IFNa and b), proteins
required for antiviral immunity that protects cells from the
infection. Previous studies have shown that the expression
of the IFNb gene is stochastic, and under optimal
conditions only a fraction of the infected cells express
the IFNb gene. At present neither the mechanisms nor
functions of this interesting phenomenon are well
understood. We have addressed this question by analyzing
IFN-expressing and non-expressing mouse cells that were
infected with the highly transmissible Sendai virus. We
show that stochastic IFNb gene expression is a conse-
quence of cell-to-cell differences in limiting levels and/or
activities of virus components at every level of the virus
induction process, from viral replication to expression.
These differences include the sensing of viral RNA by host
factors, the activation of the signaling pathway, and the
levels of activated transcription factors. Our findings reveal
the complexity of the regulatory mechanisms controlling
stochastic IFNb gene expression. We propose that the
stochastic expression of IFN allows for an even distribution
of IFN, thus avoiding over-expression of IFN in infected
cells.
Stochastic Expression of the Interferon-b Gene
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inducible genes in IFNb-expressing and non-expressing cells. As
shown in Figure 1D, transcription levels of all tested inflammatory
cytokine or chemokine genes are much higher in IFNb-producing
cells compared to nonproducers. Considering the fact that IFNb-
producing cells account for only 10% of the total cell population,
we conclude that expression of all these virus-inducible genes is
also stochastic and that these genes are coordinately activated with
the type I IFN genes. Activation of these virus-inducible genes is
known to require the RIG-I signaling pathway [28–31]. Thus, our
results indicate that stochastic gene expression is due primarily to
limiting components in the signaling pathway and not to gene-to-
gene variation in the mechanism of gene activation.
In the case of human cells, stochastic expression of the IFNb
gene is randomly monoallelic early and biallelic late in infection,
and the activation of the second IFNb allele is inducible by IFN
[20,21]. However, the nature of allelic expression of the IFNb
gene has not been addressed in mouse cells. By using IFNb/YFP
heterozygous MEFs, we showed that early after infection (,8h
post-infection [h.p.i.]), IFNb gene expression was primarily
monoallelic, while late in infection (8–16 h.p.i.), the majority of
IFNb-expressing cells were both IFNb and YFP double-positive
cells indicating that, as with human cells, a switch to biallelic
expression also occurs in mouse cells (Figure S2B).
Previous studies have shown that the levels of IFNb gene
expression can be increased by priming the cells with IFNb [13].
Using both mouse and human primary fibroblasts, we showed that
IFNb pretreatment also increases the percentages of IFNb-
expressing cells (Figure S3), indicating that the limiting factor(s)
contributing to stochastic IFNb gene expression are, indeed,
inducible by IFNb. One of these IFN-inducible factors is IRF7
([20] and see below).
Viral Replication Is More Efficient in IFNb-Producing Cells
To examine the role of the infecting virus in stochastic IFNb
gene expression, we infected primary MEFs with SeV followed by
immunofluorescent staining using a SeV antibody. As shown in
Figure S4A, most, if not all, of the cells are uniformly infected by
Figure 1. Stochastic IFN and virus-inducible gene expression. (A) Stochastic IFNb gene expression detected by ISH using a digoxygenin-
labeled IFNb RNA probe. (B) Percentage of IFNb-producing cells at different times after SeV infection. (C) Mouse IFNa gene expression in primary
MEFs detected by ISH using a digoxygenin-labeled IFNa4 probe. (D) qPCR analysis illustrating the expression levels of different virus-inducible genes
in sorted IFNb/YFP MEFs.
doi:10.1371/journal.pbio.1001249.g001
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expressing IFNb gene. When we used increasing multiplicities of
SeV (as defined by hemagglutination units [HAU]) to infect
primary MEFs, we found that the percentage of IFNb-producing
cells increased as the HAU was increased, reaching a maximum of
approximately 18% at the peak (Figure S4B). However, as more
virus was added (.200 HAU), the percentage of IFNb-producing
cells decreased. Thus, the viral titer is not a limiting factor in the
observed stochastic IFNb gene expression. Next, we determined
viral transcript levels in both IFNb-producing and nonproducing
cells. We found that the nucleoprotein (NP), matrix protein, and L
polymerase protein mRNA transcripts were present at significantly
higher levels in IFNb-producing cells compared to the nonprodu-
cers (Figures 2A and S4C). In addition, higher levels of SeV NP
protein were detected in IFNb-producing cells (Figure 2B).
The RNA helicase RIG-I detects viral genomic RNA and
defective interfering (DI) genomes [32,33]. We therefore examined
the levels of viral and DI genomes in both IFNb-producing and
nonproducing cells. As shown in Figure 2C (upper panel), more
SeV DI genomes were detected in IFNb-producing cells compared
to IFNb-nonproducing cells at 8 and 12 h.p.i. Using a primer pair
that specifically detects viral genomic RNA, we also detected more
viral genomes in IFNb-producing MEFs 8 and 12 h.p.i.
(Figure 2C, lower panel). These results are consistent with the
Figure 2. Viral transcription and/or replication are more efficient in IFNb-producing cells. (A) qPCR analysis illustrating the relative
abundance of viral NP, matrix (M), and L polymerase protein (L) mRNA in sorted IFNb/YFP MEFs. (B) Western blots showing cytoplasmic distribution of
SeV NP protein present in IFNb-producing and nonproducing cells. (C) qPCR analysis illustrating the relative abundance of SeV DI genome (upper
panel), and semi-qRT-PCR analysis illustrating the relative abundance of SeV genomic RNA (lower panel) in sorted IFNb/YFP MEFs. Reverse
transcriptase PCR was carried out to detect viral genomic RNA and host cell b-actin mRNA (control) using gene-specific primers. After 35 cycles (SeV
genomic RNA) or 26 cycles (b-actin) of amplification, PCR products were run on a 2% agarose gel. (D) Intracellular staining using SeV antibody and
FACS analysis were carried out to determine the correlation between SeV infection and IFNb expression in IFNb/YFP homozygous MEFs. IB,
immunoblot.
doi:10.1371/journal.pbio.1001249.g002
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viral replication is more efficient in the IFN-producing cells. We
also investigated the induction activities of total RNA extracted
from both IFNb-producing and nonproducing cells. As shown in
Figure S4D, total RNA from IFNb-producing cells infected for 8
or 12 h induced more IFNb expression compared to total RNA
from IFNb-nonproducers at the same time points. We conclude
that viral mRNA, DI genomes, and viral genomes are present at
higher levels in IFNb-producing cells than in nonproducers. Thus,
differences in the efficiency of viral replication/transcription
contribute to the stochastic expression of the IFNb gene.
Previous studies led to the conclusion that the stochastic
expression of the IFNb gene is a feature of the infecting virus,
and not of the host cell [22]. To address this possibility, we
determined the number of cells that have high levels of viral RNA
and produce IFNb at 8 h.p.i. As shown in Figure 2D, after 8 h of
virus infection, approximately 38% SeV-high cells (upper left and
upper right) were detected, and about 9% YFP-positive cells
(upper right and lower right). Although a higher percentage of
IFNb-expressing cells was observed within the SeV-high cell
population (6.56% versus 2.42%), only 17% (6.56% out of 38%) of
SeV-high cells produce IFN. Thus, although cell-to-cell differences
in viral replication contribute to the stochastic expression of IFN,
these differences are not sufficient to explain the extent of
stochastic IFN gene expression.
The RIG-I Signaling Pathway Is Activated and More
Potent in IFNb-Producing Cells
To further investigate the mechanism of stochastic IFNb gene
expression, we determined the localization of various components
of the signaling pathway required for IFN production using
nuclear and cytoplasmic fractions separated from both expressing
and non-expressing cells. Consistent with the limiting component
hypothesis, we detected phosphorylation and translocation of
IRF3 in the YFP-positive cells, but not in the YFP-negative cells
(Figure 3A). Previous studies have shown that IRF3, like IRF7, is
phosphorylated by the TBK1 kinase, and translocates from the
cytoplasm to the nucleus. As both IRF3 and IRF7 are activated via
the RIG-I pathway, our results suggest that one or more
components of the RIG-I signaling pathway are limiting in the
cells that fail to express IFN. A similar result was obtained with
sorted cells at 12 h.p.i. (Figure 3B).
In human cells both NF-kB and IRF3/IRF7 are required for
virus induction of the IFNb gene [12,34]. The human and mouse
IFNb enhancers differ in only two nucleotides out of 45 bases.
However, in mouse cells NF-kB is required only for early antiviral
activity, when the level of active IRF3 is low, but is not required
for maximum levels of IFNb expression late in induction [27,35].
Consistent with this finding, we show that only a small fraction of
the p65 subunit of NF-kB translocates to the nucleus 8 h.p.i., and
little difference is observed in NF-kB localization between the
YFP-positive and YFP-negative cells (Figure 3A).
The observation that IRF3 activation and translocation occurs
in only a fraction of virus-infected cells suggests that upstream
components in the RIG-I signaling pathway differ in IFNb-
producing and nonproducing cells. Western blotting results
(Figure 3C) showed that IFNb-producing cells have higher levels
of both RIG-I and MDA5 than the nonproducing population.
Trim25, an E3 ligase required for RIG-I activation [4], is also
present at a higher level in the IFNb-producing cells (Figure 3C).
The increase in protein levels appears to be a consequence of
differential transcription of the tested genes, as mRNA levels of all
three genes are higher in IFNb-producing cells (Figure 3D). We
conclude that the IFNb-producing cells have higher levels of
essential RIG-I signaling pathway components than the IFNb-
nonproducing cells. Thus, at least part of the observed stochastic
expression is due to limiting RIG-I pathway components in the
cells that do not express IFN.
By contrast to the RNA detectors, the protein levels for both
MAVS and TBK1, two essential components of the RIG-I
signaling pathway [7,9], were lower in the IFNb-producing cells
(Figure 3C). However, this is likely due to the degradation and/or
cleavage of the MAVS protein in infected cells [36–38]. The data
of Figure 3C suggest that TBK1 is also targeted for degradation
during virus infection, consistent with the observation that TBK1
is subject to proteasome-dependent degradation [39]. Thus the
turnover of both MAVS and TBK1 may be required for the post-
induction turn-off of IFNb gene expression [38].
Over-Expression of Individual Components of the RIG-I
Signaling Pathway Increases the Percentage of Cells
Expressing IFNb
We have shown that the RIG-I signaling pathway is selectively
activated in IFNb-expressing cells, and this is due only in part to
the cell-to-cell differences in virus infection/replication. Our
results also suggest that IFNb-producing cells have a more potent
signaling pathway than IFNb-non-expressing cells. To further
explore this possibility, we established a series of L929 stable cell
lines that express RIG-I, MDA5, or Trim25 under the control of a
tetracycline-inducible promoter (Figure S5A). As shown in Figure
S5B and S5C, high levels of exogenous RIG-I only slightly
increased the percentage of IFNb-producing cells. A larger
increase was observed with MDA5 and Trim25, but the final
percentage in both cases was still under 30%. Thus, these
upstream components appear to be among several limiting factors
in the cell population.
Additional components in the RIG-I signaling pathway were
tested using the same approach, and high percentages of IFNb-
producing cells were observed (Figure 4A and 4B). While a large
difference between tetracycline-negative and tetracycline-positive
cells was observed with the TBK1 line, only a small difference was
observed between the corresponding MAVS lines. However, a
large difference was observed between the non-transformed and
transformed MAVS lines, suggesting that a low level of leaky
transcription in the MAVS line is sufficient to dramatically
increase the number of IFNb-expressing cells. These data clearly
indicate that both MAVS and TBK1 are limiting components in
the RIG-I pathway and therefore contribute significantly to
stochastic IFNb expression.
We have shown that over-expression of RIG-I or Trim25 alone
only slightly increases the percentage of IFNb-producing cells, but
it is possible that both must be expressed to achieve maximum
levels of IFNb production. We therefore transfected RIG-I stable
transfectants with a Trim25 expression plasmid, and the other way
around. The cells were then induced with tetracycline, infected
with SeV, and examined for IFNb mRNA expression. Control
experiments using a GFP reporter indicated that under our
experimental conditions approximately 70% of cells can be
transfected with the second plasmid (Figure S5D). As shown in
Figure 4C and 4D, a dramatic increase was observed only 6 h.p.i.
when either the RIG-I or Trim25 lines were transfected with
Trim25 or RIG-I, respectively. This observation was confirmed by
carrying out intracellular staining and flow cytometry experiments
using IFNb/YFP homozygous MEFs (Figure S6). We conclude
that the combination of RIG-I and Trim25 is limiting in the RIG-I
pathway.
We note that the increase of IFNb-expressing cells was not
observed in uninfected cells, with the only exception being MAVS.
Stochastic Expression of the Interferon-b Gene
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bypass the requirement for signaling pathway activation.
IRF7 Is a Primary Limiting Factor in Stochastic IFN Gene
Expression
Expression of the IFNb gene requires an active RIG-I signaling
pathway and assembly of the enhanceosome complex on the IFNb
promoter. To investigate whether individual enhanceosome
components are limiting factors, we established a series of
tetracycline-inducible L929 stable lines that express IRF3, IRF7,
or p65 genes. Figure 5A and 5B show that, without tetracycline
induction, only 10%–15% of the cells produce detectable levels of
IFNb mRNA in response to virus infection. Remarkably, the
percentage of IFNb-producing cells upon SeV infection increased
Figure 3. The RIG-I signaling pathway is activated in IFNb-producing cells. (A and B) Western blots showing cytoplasmic (C) versus nuclear
(N) distribution of different factors present in FACS-sorted cells 8 h.p.i. (A) and 12 h.p.i (B). (C) Western blots showing cytoplasmic distribution of
signaling pathway proteins present in FACS-sorted cells 8 h.p.i. Arrows indicate MAVS protein. (D) qPCR analysis illustrating the expression levelso f
RIG-I, Trim25, and MDA5 genes in sorted IFNb/YFP homozygous MEF cells 8 h.p.i. IB, immunoblot.
doi:10.1371/journal.pbio.1001249.g003
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every cell (Figure S7A). A smaller increase (55%) was observed
when IRF3 was over-expressed, whereas increasing the concen-
tration of NF-kB had little effect, consistent with the data in
Figure 3A, and previously published studies [27]. Interestingly,
IRF7 over-expression also significantly increased the percentage of
IFNa-producing cells after virus infection (Figure S7B and S7C). It
is known that IRF7 is required for maximum induction of type I
IFN genes [25], and its basal protein level is very low in most cell
types except for plasmacytoid dendritic cells [26,40]. We conclude
that IRF7 is a critical limiting factor that is a major contributor to
stochastic expression of mouse IFNa and b genes. This conclusion
is also supported by our ISH results from 4E-BP1/4E-BP2 double-
knockout MEFs (Figure 5C and 5D). Previous studies have
indentified 4E-BPs as negative regulators of type I IFN production
via translational repression of IRF7 mRNA [41]. As shown in
Figure 5C and 5D, we observed a 4-fold increase of the percentage
of IFNb-expressing cells in 4E-BP1/4E-BP2 double-knockout
MEFs compared to wild-type MEFs, consistent with the
conclusion that a limiting amount of IRF7 is a major contributor
to the stochastic expression of IFNb.
We also found that type I IFN induction was exceptionally high,
with much faster kinetics in cells expressing exogenous IRF7 than
in control cells (Figure S7D). In the absence of tetracycline
induction, low levels of IFNb, IFNa4, and IFNa2 mRNA were
first detected 6 h, 9 h, and 12 h.p.i., respectively. When the cells
were treated with tetracycline, the kinetics of IFN gene
transcription changed significantly. IFNb, IFNa4, and IFNa2
transcripts could be detected as early as 4 h after virus infection.
Even at 24 h.p.i., steady and robust transcription of these genes
could still be detected. These observations are consistent with a
model in which IRF3 is normally activated early for IFN gene
induction. Later, higher levels of IRF7 are produced by IFN and
are required for both IFNb and IFNa gene expression, but IRF7 is
rapidly turned over, leading to the cessation of both IFNb and
IFNa gene expression [1,25,26]. By contrast, in the presence of
excess IRF7 in the tetracyline-activated cells, both IFNb and IFNa
are activated earlier, and continue to be expressed because of the
continuous presence of IRF7.
IRF7 Positively Regulates the RIG-I Signaling Pathway
We have shown that over-expression of IRF7 or both RIG-I
and Trim25 almost completely eliminates stochastic IFNb
expression (Figures 4C, 4D, and 5). To investigate the connection
between these observations, we carried out microarray analysis to
compare genome-wide expression profiles of L929-IRF7 stable
transfectants treated with or without tetracycline. Interestingly,
upon IRF7 over-expression, only two up-regulated signaling
pathways were identified from the KEGG Pathway Database,
and the RIG-I-like receptor signaling pathway is the most up-
regulated (p=3.6E-06) (Figure S8A and S8B) [42]. We did not
identify signaling pathways that were similarly enriched among the
down-regulated genes. Using qPCR, we confirmed that the
mRNA levels of both RIG-I and Trim25 were higher in IRF7
over-expressing cells (Figure S8C). Considering the low basal
expression level of IRF7, we conclude that a high level of IRF7
protein increases the percentage of IFNb-expressing cells not only
by increasing its own abundance, but also by up-regulating the
RIG-I signaling pathway to increase the potency of activation of
the IFNb gene.
Stochastic Expression of IFNb Induced by dsRNA—poly
I:C Is Due to Limiting Amounts of MDA5 and IRF7
IFNb gene expression can also be induced by transfection of the
synthetic dsRNA polyriboinosinic polyribocytidylic acid (poly I:C),
and this induction occurs mainly through the MDA5 signaling
pathway [43]. Early studies revealed that induction of IFNb
expression by dsRNA treatment is also stochastic [13,14]. We
therefore asked whether stochastic IFNb gene expression induced
by dsRNA is due to cell-to-cell variation in the levels of MDA5
and IRF7. Using FACS analysis, we found that poly I:C–induced
IFNb expression is also stochastic (Figure 6A). When IFNb/YFP
homozygous MEFs were electroporated with Cy5-labeled poly
I:C, only 9% of the cells produced IFNb as detected by the
presence of YFP. However, the electroporation efficiency was over
99% (Figure 6A, left panel). Interestingly, based on the Cy5
intensity, there were two populations of cells, which contained
different amounts of poly I:C. When we gated these two
populations out as ‘‘poly I:C–high’’ and ‘‘poly I:C–low’’, we
observed that the ‘‘poly I:C–high’’ population included more cells
producing IFNb (Figure 6A, right panel), indicating that the
amount of inducer does affect the extent of stochastic IFNb
expression. However, only a small percentage of ‘‘poly I:C–high’’
cells expressed the IFNb gene, clearly indicating that other limiting
factor(s) dominate the stochastic IFNb expression induced by poly
I:C transfection. We therefore carried out experiments to identify
these limiting components.
L929-MDA5 and L929-RIG-I stable transfectants were trans-
fected with poly I:C followed by ISH to detect IFNb expression. As
shown in Figure 6B and 6C, over-expression of RIG-I only slightly
increased the percentage of IFNb-producing cells. By contrast
over-expression of MDA5, the major cytoplasmic receptor for poly
I:C, led to a substantial increase in the percentage of IFNb-
producing cells (from 15% to 65%). Considering that the
transfection efficiency is approximately 75% (data not shown),
over-expression of MDA5 basically eliminates stochastic expres-
sion of the IFNb gene in response to poly I:C transfection.
Furthermore, the results of the flow cytometry experiment also
supported this conclusion. As shown in Figure 6D, after 8 h of poly
I:C stimulation, we observed approximately 2.6% YFP-positive
cells. Within this population, about 70% of the YFP-positive cells
had higher levels of MDA5 protein (1.86% out of 2.67%). We note
that the percentage of YFP-positive cells is much lower than that
observed with virus infection (Figures 2D and S6).
Over-expression of IRF3 or IRF7 also increased the percentage
of IFNb-producing cells in response to poly I:C (Figure S9A and
S9B). As shown in Figure S8, over-expression of the IRF7 gene up-
regulates MDA5 gene expression. Considering its low basal
expression level, IRF7 is also an important limiting factor in
stochastic IFNb expression induced by poly I:C transfection.
Taken together, these data show that poly I:C–induced stochastic
IFNb expression depends on the abundance of both poly I:C and
Figure 4. Limiting factors in stochastic IFNb gene expression. (A) Different L929 stable transfectants were induced by tetracycline (Tet) for
24 h, followed by SeV infection for 9 h. RNA ISH experiments were carried out to detect the IFNb mRNA. (B and D) Histograms showing the
percentage (mean 6 standard deviation) of cells expressing IFNb from three independent ISH experiments. At least 400 cells were blindly counted
and scored for each category. (C) L929 stable transfectant was transiently transfected with expression vectors encoding either GFP (control), RIG-I,o r
Trim25, then stimulated with tetracycline for 24 h. Cells were then infected with SeV for 6 h, followed by RNA ISH to detect IFNb mRNA. pt, pt-REX-
DEST30.
doi:10.1371/journal.pbio.1001249.g004
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similar to what was found in the case of virus infection.
Variation in the Levels of RIG-I Signaling Pathway
Components
We also asked whether the concentrations of proteins regulating
IFNb expression are sufficiently different from cell to cell to
account for the stochastic IFNb expression. Using flow cytometry,
we measured the distributions of six components in the RIG-I
signaling pathway for which specific antibodies are available. As
shown in Figure 7A and 7B, all six proteins were log-normally
distributed across the population. Quantitative immunofluores-
cence data for individual components show similar distributions of
each factor at the single-cell level (Figure S10). Combined with our
previous data, these observations suggest that naturally occurring
differences in the protein levels of signaling pathway components
are the primary cause of cell-to-cell variability in IFNb expression
upon virus infection.
IFN-Inducible Antiviral Genes Are Not Stochastically
Expressed
When IFN is secreted from virus-infected cells in vivo, it binds
to type I IFN receptors on surrounding cells and activates a large
set of genes encoding antiviral proteins (interferon-stimulated
genes [ISGs]) via the Jak/STAT signal transduction pathway. We
therefore carried out experiments to determine whether the
induction of antiviral ISGs is also stochastic. As shown in
Figure 7C, ISG15 is expressed in all cells upon treatment with
IFNb. Thus, when IFN is secreted, all of the surrounding cells
produce antiviral proteins. This result is also consistent with
previous observations showing that the antiviral response induced
by IFN is a robust feature common to all cells, and is independent
of the stochastic expression of IFN receptor IFNAR [44].
Discussion
Regulation of type I IFN production is essential for the innate
immune response to viral infections [45,46]. However, high levels
of IFNb can be toxic [47,48]. Thus, IFNb production must be
tightly regulated. This regulation appears to be both temporal and
stochastic. Type I IFN genes are tightly repressed prior to virus
infection, activated upon infection, and then rapidly turned off
several hours later (Figure S1B and S1C). Previous studies of
several cytokine genes suggest that this stochastic gene expression
provides an additional mechanism of regulation whereby optimal
levels of cytokine production are determined by the frequency of
expressing cells rather than by protein levels per cell [18,19,49].
Thus, it is possible that stochastic expression is a primary
mechanism for controlling the optimal level of IFNb production
in vivo. In particular, we have shown that while IFN production is
stochastic, the activation of the antiviral gene program by secreted
IFN is not. Thus, stochastic expression of IFN would allow the
regional distribution of the cytokine and activation of the
surrounding cells, without producing toxic levels of IFN.
Previous studies have implicated as limiting steps enhanceosome
assembly [20,21] and the assembly of an interchromosomal
transcriptional hub formed through interactions between Alu
elements bearing NF-kB sites [20]. More recently, the infecting
virus, rather than intrinsic properties of the infected cell, has been
implicated in this stochasm [22]. The data presented here reveal a
far more complex mechanism in which cell-to-cell variations in
limiting components required to support viral replication, to detect
and signal the presence of viral RNA, and to activate transcription
factors all contribute to the observed stochastic expression
(Figure 7D). It seems likely that the key limiting factor varies
between cell types, cell lines, and organisms.
The earliest step in the virus induction signaling pathway is
entry of virus or dsRNA into the cell. We have shown that both
inducers elicit stochastic expression, but in neither case is this due
to limiting inducer (Figures S4B and 6A). We showed that both
IFNb-producing and nonproducing cells were infected by SeV
(Figure 2B). However, the IFNb-producing cells contained
significantly higher levels of the products of viral replication and
transcription. Thus, it appears that there are cell-to-cell differences
in the ability to support efficient viral replication, and these
differences influence the probability of IFNb gene expression.
Presumably, high levels of RNA inducer in the IFN-producing
cells overcome limiting amounts of RIG-I or MDA5. However,
differences in viral replication alone cannot explain the observed
stochasm in IFNb production. A previous study, using a cell line
transfected with an IFNb-GFP reporter, concluded that stochastic
IFNb expression is due entirely to heterogeneity in the infecting
virus [22]. However, in that study the IFNb-GFP cell line was
preselected to minimize stochastic expression of the reporter. In
addition, that study involved a stably transfected gene, while the
present study made use of the endogenous gene. The results
presented here strongly indicate that heterogeneity of both the
virus and host cells together are responsible for the stochastic
expression of IFNb.
We have identified multiple limiting steps in the activation of
IFNb gene expression, ranging from initial steps in virus infection
and replication, to the signaling pathway, to the activation and
binding of transcriptional activator proteins to the IFNb promoter.
For example, over-expression of individual components in the
RIG-I signaling pathway increases the percentage of IFN-
expressing cells. The largest increase was observed with IRF7,
which lies at the endpoint of the RIG-I pathway, and also
positively controls the expression of components in the RIG-I
signaling pathway. Taken together, these data are consistent with
a model in which the probability of expression of the IFNb gene in
individual cells depends primarily on the activation of the RIG-I
signaling pathway and the presence of sufficient numbers of IRF7
molecules to activate transcription (Figure 7D). This conclusion is
consistent with the observation that both IFNb and IFNa are
stochastically expressed in response to virus infection (Figure 1A
and 1C). The expression of both genes requires activation of the
RIG-I pathway and active IRF7 [50].
We find that limiting amounts of other RIG-I pathway
components also contribute to stochastic expression of the IFNb
gene, as we observed higher levels of RIG-I/Trim25 and MDA5
mRNA and protein levels in the IFNb-producing cells than in the
nonproducers (Figure 3). In addition, over-expression of RIG-I
and Trim25 together leads to a dramatic increase in the
percentage of cells that express IFNb (Figure 4C and 4D). Similar
Figure 5. IRF7 is the significant limiting factor in stochastic type I IFN gene expression. (A) Different L929 stable transfectants were
induced by tetracycline (Tet) for 24 h, followed by SeV infection for 9 h. RNA ISH experiments were carried out to detect IFNb mRNA. (B and D)
Histograms showing the percentage (mean 6 standard deviation) of cells expressing IFNb from three independent ISH experiments. At least 400 cells
were blindly counted and scored for each category. (C) RNA ISH experiments were carried out to detect IFNb mRNA in wild-type (W.T.) or 4E-BP
double-knockout (DKO) MEFs infected by SeV for 9 h.
doi:10.1371/journal.pbio.1001249.g005
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signaling components MAVS and TBK1 and the transcription
factors IRF3 and IRF7 (Figures 4A, 4B, and 5). Thus, it appears
that many, if not all, of the components in the RIG-I signaling
pathway, from the sensors of viral RNA to the essential
transcription factors, can be limiting components in the virus
induction pathway.
The largest increase in the percentage of IFN-producing cells
was observed when IRF7 was over-expressed. IRF7 is the master
regulator of type I IFN gene expression [25], and is present at low
levels in all cell types except plasmacytoid dendritic cells, where it
is constitutively abundant [26,40]. Our over-expression experi-
ments show that high levels of IRF7 promote the transcription of
type I IFN genes (Figure S7D), and essentially eliminate the
stochastic expression of both the IFNb and a genes (Figures 5 and
S7). In a previous study in human cells, both NF-kB and IRF7
over-expression was shown to partially suppress stochastic IFNb
expression [20]. Our results are consistent with this observation.
However, there are two differences. First, based, at least in part, on
the lack of requirement of NF-kB in murine cells, we observed a
relatively small effect of increasing NF-kB expression. Second, we
saw a greater effect of IRF7 expression in murine cells than was
observed in human cells. Over-expression of IRF7 in L929 cells
almost completely eliminated stochastic expression of both IFNb
and a genes, while in human HeLa cells high levels of IRF7
increase the percentage of IFNb-producing cells to almost 55%
[20]. Deleting the IRF7 translational repressors, 4E-BPs, also
increased the IFNb-expressing MEFs by 4-fold (Figure 5C and
5D). We also showed that the RIG-I signaling pathway, and in
particular RIG-I and Trim25, are up-regulated in IRF7 over-
expressing cells (Figure S8). We conclude that limiting amounts of
active IRF7 appear to be overcome by two mechanisms: positive
auto-regulation of IRF7 expression, and IRF7-dependent up-
regulation of the RIG-I signaling pathway.
We note that in addition to IFNb, several other virus-inducible
genes, including TNFa, IL-6, CCL4, and CCL5, are highly
expressed in the IFNb-producing cells compared to nonproducers,
suggesting that many, if not all, of the virus-inducible genes are
stochastically expressed. The common feature of the activation of
all of these genes is that they all require the RIG-I signaling
pathway [28–31]. Thus, we conclude that stochastic gene
expression is primarily due to limiting components in the signaling
pathway but not gene-to-gene variation in the mechanism of gene
activation.
We showed that although the IFNb gene is stochastically
expressed upon virus infection, the antiviral ISGs, e.g., ISG15,
were equally induced in all cells (Figure 7C). However, we note
that RIG-I, Trim25, and MDA5, which are also antiviral ISGs,
are highly expressed in IFNb-producing cells compared to
nonproducing cells (Figure 3C and 3D). We believe that the
differences we observed here reflect naturally occurring cell-to-cell
variability in the levels of expression of these genes prior to virus
infection, and that this variability is the primary source of
stochastic IFNb gene expression. However, at later times after
virus infection, we expect that the differences in the mRNA or
protein levels of these genes between the YFP-positive and YFP-
negative populations will be much smaller compared to those at
earlier stages (8 h.p.i.). As shown in Figure S11A and S11B, our
qPCR data and Western blot data support this expectation. The
IFNb gene is also stochastically expressed in IFNAR-deficient
MEFs, which suggests that the IFNAR levels or an IFNb feedback
loop are not major factors responsible for stochastic IFNb gene
expression (Figure S11C). We further measured the distributions
of six components in the RIG-I signaling pathway. As shown in
Figures 7A, 7B, and S10, all six proteins were log-normally
distributed across the cell population, an observation that is
consistent with data on other proteins [51,52]. Thus, naturally
occurring differences in the protein levels and activities of
individual signaling pathway components and transcription factors
account for stochastic IFNb expression induced by both poly I:C
induction and virus infection.
Previous studies have shown that naturally occurring differences
in the levels of proteins in the apoptotic signaling pathway are the
primary reasons for cell-to-cell variability in the probability of cell
death [52]. Thus, the results presented here not only reveal the
complexity of the regulatory mechanisms controlling stochastic
IFNb gene expression, but also suggest a general mechanism used
in different biological processes to establish and control stochastic
gene expression. A remarkable feature of stochastic expression is
that it appears to be an intrinsic property of different clonal
populations of cells. For example, if a particular cell line displays a
certain percentage of activated cells, that percentage differs from
other cell lines, and is retained when the cells are recloned [14].
Thus, the extent of stochasm appears to be a genetic and
epigenetic feature of clonal cell populations.
Materials and Methods
Cells, Reagents, and Plasmids
All cell lines, including L929, RAW 264.7, MG63, and 293T,
were from the American Type Culture Center; primary MEFs
were isolated using standard protocols from IFNb/YFP mice [24].
Primary human foreskin fibroblast cells were purchased from
PromoCell. All cells were cultured in DMEM (Gibco) supple-
mented with 10% FBS (Gibco) in a 5% CO2 incubator.
Cycloheximide was purchased from Sigma-Aldrich. Human and
mouse recombinant IFN proteins were purchased from PBL
Interferonsource. Brefeldin A solution was purchased from
eBioscience. Poly I:C was purchased from InvivoGen. Cy5-labeled
poly I:C was generated using Label IT Nucleic Acid Labeling Kit
(Mirus). The different expression constructs were generated by
cloning the coding sequences of each gene by PCR and inserting
them into the vector pt-REX-DEST30, which has the tetracycline-
inducible promoter (Invitrogen).
Figure 6. Poly I:C–induced stochastic IFNb expression depends on the amounts of poly I:C and MDA5. (A) IFNb/YFP homozygous MEF
cells were electroporated with Cy5-labeled poly I:C, and FACS analysis was carried out 8 h after the electroporation to assay the strength of Cy5 and
YFP. The top left panel shows untransfected MEF cells, and the bottom left panel shows the electroporated MEF cells. As indicated by arrows, the two
panels to the right represent the ‘‘poly I:C high’’ and ‘‘poly I:C low’’ populations, respectively. Data shown are representative of at least three
independent experiments. Numbers represent relative percentages. (B) L929-MDA5 or L929-RIG-I stable transfectants were stimulated with
tetracycline (Tet) for 24 h followed by transient transfection with poly I:C. 6 h after transfection, cells were fixed, followed by RNA ISH to detect IFNb
mRNA. (C) Bar plots representing the percentage (mean 6 standard deviation) of cells expressing IFNb from three independent ISH experiments
performed as in (B). At least 400 cells were blindly counted and scored for each category. (D) IFNb/YFP primary MEFs were fixed 8 h after poly I:C
stimulation. Intracellular staining using MDA5 antibody and FACS analysis were carried out to assay the correlation between the expression levels of
IFNb and MDA5. Data shown are representative of at least three independent experiments. Numbers represent relative percentages. Iso-Ctrl, isotype
control.
doi:10.1371/journal.pbio.1001249.g006
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Concentrated SeV stock (Cantell strain, Charles River Lab) was
added to cultured cells at a concentration of 200 HAU/ml and
incubated for the times indicated. Poly I:C transfection was carried
out using either lipofectamine2000 (Invitrogen) or electroporation
using Amaxa MEF2 Nucleofector Kit (Lonza).
RNA Preparation and PCR
Total RNA was extracted with Trizol reagent (Invitrogen).
Real-time quantitative reverse transcription PCR (qRT-PCR) was
conducted according to standard protocols.
Antibodies and Western Blot
Antibody against YFP was from Chemicon (Millipore) or
Abcam. RIG-I, MAVS, and GAPDH antibodies were from Cell
Signaling. Antibodies against p65, HDAC1, and Trim25 were
from Santa Cruz Biotechnology. MDA5 and TBK1 antibodies
were from Abcam and Imgenex, respectively. IFNb antibody used
for FACS was from Millipore. SeV antibodies were kindly
provided by Dr. Atsushi Kato (National Institute of Infectious
Diseases, Japan). Nuclear/cytosol fractionation was performed
using Nuclear/Cytosol Fractionation Kit (BioVision). Western
blots were carried out using standard protocols.
In Situ Hybridization
Antisense RNA probes recognizing mouse IFNb or b-actin were
synthesized using T7 or SP6 polymerase and digoxigenin-labeled
nucleotides (Roche Applied Science). Cells were cultured on poly-
D-lysine-coated 24-well plates (Fisher) and either mock- or virus-
infected for the times indicated. Cells were then washed twice with
PBS and fixed with 4% paraformaldehyde. Hybridization, washes,
and staining were carried out as previously described [53].
Flow Cytometry
MEF cells were fixed with IC Fixation Buffer and permeabilized
with Permeabilization Buffer (both from eBioscience). After
incubation with appropriate antibodies, flow cytometry was done
with a FACSCalibur, and data were analyzed with CellQuest
software (both from Becton Dickinson).
Microarray Analysis and KEGG Pathway Enrichment
Analysis
Total RNA from untreated and tetracycline-induced L929-
IRF7 cells were prepared using Trizol reagent (Invitrogen)
followed by purification using MEGAclear (Ambion). Biotinylated
RNA probes were synthesized by two rounds of amplification
using the MessageAmp II aRNA Amplification kit (Ambion). The
probes were hybridized with Affymetrix Mouse Genome
430A_2.0 array chips. Affymetrix DAT files were processed using
the Affymetrix Gene Chip Operating System to create CEL files.
Normalized expression values were analyzed with the Bioconduc-
tor Limma package, an approach for implementing empirical
Bayes linear modeling [42]. For all comparison tests, genes with an
absolute fold change in transcript level exceeding 1.5 and p,0.05
were selected for further analyses. The likelihood of overrepre-
sentation of KEGG signaling pathways in the up- or down-
regulated gene list relative to a background of all array genes was
calculated by Fisher’s exact test for statistical analysis.
Supporting Information
Figure S1 Stochastic expression of IFNb gene upon virus
infection. (A) Stochastic expression of human IFNb gene in
primary foreskin fibroblast cells, MG63 cells, and 293T cells
6 h.p.i., detected by ISH using a digoxygenin-labeled antisense
RNAIFNb probe.Numbers on the right indicate the percentages of
IFNb-expressing cells in each cell type. (B and C) Kinetics of IFNb
expression in primary MEFs (B) or L929 cells (C) assayed by qRT-
PCR. IFNb mRNA can be detected as early as 6 h.p.i., and
maximum levels are observed at 9 and 12 h.p.i. in MEFs and L929
cells, respectively. (D) b-actin mRNA in L929 cells was detected by
ISH using either digoxygenin-labeled sense or antisense RNA
probe.(E)MEFcellsorhumanMG63 cellswereinfected bySeVfor
9 h or 6 h, respectively. ISH was carried out to detect the IFNb-
expressing cells using an IFNb sense or antisense probe. (F) Human
MG63 cells were infected by SeV for 9 h. IFNb protein was
detected by immunocytochemistry using IFNb antibody. Similar
percentages of IFNb-expressing cell were detected by either ISH or
immunocytochemistry. (G) Human IFNa8 mRNA in Namalwa
cells was detected by ISH using digoxygenin-labeled probe.
(TIF)
Figure S2 IFN expression in sorted MEFs and allelic
expression of IFNb gene. (A) qRT-PCR analysis illustrating
the expression levels of IFN genes in sorted IFNb/YFP primary
MEF cells. (B) IFNb/YFP heterozygous MEFs (upper panel) and
homozygous MEFs (lower panel) were infected by SeV for variable
times with the presence of Brefeldin A (BFA)—which inhibits
transport of proteins from endoplasmic reticulum to Golgi—in the
last 4 h. Cells were fixed and stained for intracellular IFNb and
YFP. If IFNb gene is monoallelically expressed, heterozygous
MEF cells should have similar percentages of IFNb-positive
population (from IFNb allele) and IFNb/YFP double-positive
population (from IFNb-IRES-YFP allele). If IFNb gene is
biallelically expressed, all, or at least most, of IFNb-expressing
heterozygous cells should be both IFNb- and YFP-positive.
Heterozygous MEF FACS analysis (upper panel) showed a similar
percentage of IFNb-positive population (upper left panel, 5.24%)
and IFNb/YFP double-positive population (upper right panel,
6.30%) at 8 h.p.i., suggesting that the IFNb gene expression was
predominantly monoallelic before 8 h.p.i. During the time periods
8–12 h.p.i. and 12–16 h.p.i., the majority of IFNb-expressing cells
were IFNb/YFP double-positive (upper right panel, 11.01%, and
upper right panel, 3.90%, respectively), indicating that at late
infection, IFNb gene expression was biallelic. As control, shown in
the lower panel, IFNb-expressing homozygous MEF cells had
almost no IFNb single-positive population at any given time point.
Data shown are representative of at least three independent
experiments. Numbers represent relative percentages.
(TIF)
Figure S3 Priming of cells increases the percentage of
IFNb-expressing cells. (A) Primary MEFs were primed with
250 U/ml IFNb or 250 U/ml IFNb plus 50 mg/ml cycloheximide
(CHX) for 6 h, infected by SeV, and subjected to ISH using
digoxygenin-labeled IFNb RNA probe. (B) Histogram showing the
percentage (mean 6 standard deviation) of cells expressing IFNb
from three independent ISH experiments as in (A). (C) Human
foreskin fibroblasts were primed with 250 U/ml IFNb or 250 U/
ml IFNb plus 50 mg/ml cycloheximide for 6 h, infected by SeV,
shown. Short black lines represent viral inducer. Only two cells in the population have enough of the viral inducer and all six factors to trigger
transcription of the IFNb gene. Iso-Ctrl, isotype control.
doi:10.1371/journal.pbio.1001249.g007
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probe. (D) Histogram showing the percentage (mean 6 standard
deviation) of cells expressing IFNb from three independent ISH
experiments as in (C).
(TIF)
Figure S4 Viral titer is not a limiting factor. (A) MEF cells
were infected by SeV. Cells were fixed and stained for SeV using
SeV antibody. Blue color shows DAPI staining (nucleus) and green
color shows SeV signal. Most, if not all, cells are uniformly
exposed to SeV. Scale bar, 20 mm. (B) Percentages (mean 6
standard deviation) of IFNb-producing primary MEF cells infected
by increasing amounts of SeV. At least 400 cells were counted and
scored blindly for each category. In all of the experiments
described in this study, we used 100–200 HAU/ml of SeV as the
infecting dose. (C) qRT-PCR analysis illustrating the relative
abundance of viral NP mRNA in sorted IFNb/YFP primary MEF
populations 8 or 12 h.p.i. (D) L929 cells were transfected with total
RNAs either from IFNb-producing or IFNb-nonproducing MEF
cells sorted after being virus-infected for 8 h or 12 h. Then total
RNAs were extracted from these L929 cells 8 h after transfection,
and qRT-PCR experiments were carried out to detect relative
abundance of IFNb mRNA in these transfected cells.
(TIF)
Figure S5 Over-expression of RIG-I, MDA5, or Trim25
increases the percentage of IFNb-expressing cells.
Different tetracycline-inducible L929 stable transfectants were
generated. In the absence of tetracycline, expression of exogenous
copies of these genes is tightly repressed in the stable transfectants,
but upon the addition of 1 mg/ml tetracycline, the stably
incorporated genes are expressed at a high level. (A) Western
blots showing the tetracycline-inducible expression levels of
different proteins. All genes were flag tagged and proteins were
detected using Flag antibody. (B) L929-RIG-I, L929-MDA5, and
L929-Trim25 stable transfectants were induced by tetracycline for
24 h, followed by virus infection for 9 h. RNA ISH experiments
were carried out to detect the IFNb mRNA. (C) Histogram
showing the percentage (mean 6 standard deviation) of cells
expressing IFNb from three independent ISH experiments. At
least 400 cells were blindly counted and scored for each category.
(D) L929-RIG-I stable transfectants were transfected with GFP
control plasmid. The transfection efficiency was measured by GFP
detection using fluorescent microscopy.
(TIF)
Figure S6 Higher RIG-I and Trim25 protein levels are
present in IFNb-expressing cells. IFNb/YFP homozygous
MEF cells were infected with SeV for 8 h. Cells were then fixed
and intracellularly stained for RIG-I and Trim25. FACS analysis
was used to assay the correlation between IFNb expression
(detected by YFP) and RIG-I/Trim25 expression. The top panel
shows the expression of RIG-I and Trim25 in MEFs before and
after virus infection. The middle panel shows the percentage of
IFNb-expressing cells before and after virus infection. The bottom
panel shows the RIG-I/Trim25 expression level in YFP-positive
cells in the middle panel, which represent IFNb-expressing cells.
Data shown are representative of at least three independent
experiments. Numbers represent relative percentages.
(TIF)
Figure S7 Over-expression of IRF7 eliminates stochas-
tic IFNa gene expression. (A) L929-IRF7 stable transfectants
were treated with 1 mg/ml tetracycline for 24 h followed by
immunocytochemistry using Flag antibody detecting the exoge-
nous Flag-tagged IRF7 expression level. Increased IRF7 expres-
sion level was detected in almost every cell. Scale bar, 20 mm. (B)
The L929-IRF7 stable transfectant was induced by tetracycline for
24 h, followed by virus infection for 9 h. RNA ISH experiments
were carried out to detect IFNa mRNA. (C) Histogram showing
the percentage (mean 6 standard deviation) of cells expressing
IFNa from three independent ISH experiments. At least 400 cells
were blindly counted and scored for each category. (D) L929-IRF7
stable transfectants were treated with or without tetracycline for
24 h before SeV infection. Total RNA was extracted and semi-
qRT-PCR was carried out to measure the kinetics of transcription
of different type I IFN mRNAs.
(TIF)
Figure S8 IRF7 up-regulates RIG-I-like receptor signal-
ing pathway. (A) Partial list of genes whose expression in L929-
IRF7 cells, as assessed by genome-wide expression profiling, was
increased as a result of tetracycline induction to the level of these
genes in control cells without tetracycline treatment. The names of
known RIG-I-like signaling pathway genes from the KEGG
Pathway Database are highlighted in grey. Asterisk indicates that
the Ddx58 gene expression profile was undetectable because of the
lack of a corresponding probe set on the Affymetrix Mouse
Genome 430A_2.0 array chips. The fold increase of Ddx58 gene
expression was determined by qRT-PCR. (B) RIG-I-like receptor
signaling pathway is the most significantly up-regulated pathway
identified from KEGG pathway enrichment analysis (p=3.6E-06)
based on L929-IRF7 microarray results. *, p,0.05; ***, p,0.001.
(C) qRT-PCR analysis illustrating the levels of expression of IRF7,
RIG-I, Trim25, and MDA5 in L929-IRF7 stable transfectants
before and after induction with tetracycline.
(TIF)
Figure S9 IRF3 and IRF7 are limiting factors in
stochastic IFNb expression induced by poly I:C trans-
fection. (A) L929-IRF3, L929-IRF7, or L929-p65 stable
transfectants were stimulated with tetracycline for 24 h followed
by transient transfection with poly I:C. 12 h after transfection, cells
were fixed followed by RNA ISH to detect IFN-b mRNA. (B) Bar
plots representing the percentage (mean 6 standard deviation) of
cells expressing IFNb from three independent ISH experiments
performed as in (A). At least 400 cells were blindly counted and
scored for each category.
(TIF)
Figure S10 Endogenous variation in the concentrations
of components of the RIG-I signaling pathway. Primary
MEF cells were fixed by 4% PFA followed by intracellular staining
using appropriate antibodies recognizing different components of
the signaling pathway. The intensity of immunofluorescent signal
was quantified using ImageJ software. For individual factors, the
highest immunofluorescence intensity was set as 1. The x-axis
shows the relative immunofluorescence intensity of each factor.
Each plot represents the immunofluorescence intensity calculated
from 150–200 cells.
(TIF)
Figure S11 Differences in the levels of RIG-I signaling
pathway factors between YFP-positive and YFP-negative
populations. (A) qPCR analysis illustrating the expression levels
of IFNb, RIG-I, Trim25, and MDA5 genes in sorted MEF cells at
8, 12, and 24 h.p.i. (B) Western blots showing cytoplasmic
distribution of signaling pathway proteins present in FACS-sorted
cells at 8, 12, and 24 h.p.i. (C) IFNAR-deficient MEFs were
infected by SeV. IFNb expression was detected by ISH using IFNb
antisense RNA probe.
(TIF)
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